Braintale développe des solutions logicielles SaaS pour quantifier les lésions cérébrales profondes, prédire l’émergence du coma et aider les médecins et familles à la prise de décision concernant le maintien en vie des patient·e·s. Ces solutions ouvrent aussi à la voie à la prise en charge de maladies chroniques et dégénératives du cerveau.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.11.2020 | Seed | $1.18M | - |
Mentions in press and media 3
| Date | Title | Description |
| 10.11.2020 | BrainTale Raises €1M in Seed Funding Round | BrainTale, a Paris, France-based adapted care company, raised €1m in seed funding.
The round comprises a loan from Bpifrance and Angels Santé, the instruction persuaded Paris Business Angels, Femmes Business Angels and Arts&Metiers Busi... |
| 11.12.2019 | Headstart Day in France: Extra funding, mentoring | In July 2019, EIT Health France awarded Headstart grants of €40,000 each to 15 start-ups as part of the Headstart Funding Programme, which accelerates the market launch of selected healthcare start-ups through grants as well as support with... |
| - | Braintale | “Home - Braintale” |
Reviews 0
